However, HCC samples in advanced clinicopathological stage (Stages III–IV or T3–4, P < 0.001) and high level of AFP (AFP >400, P = 0.0492) were positively correlated with the risk score (Figures 5A–H), reflecting that the CCS-based risk score was involved in HCC progression. This evidence concerns the gene AFP and hepatocellular carcinoma.